SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:oru-111035"
 

Search: onr:"swepub:oai:DiVA.org:oru-111035" > Patient-Specific Me...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Patient-Specific Measurable Residual Disease Markers Predict Outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell Transplantation

Tobiasson, Magnus (author)
Karolinska Institutet,Karolinska Univ Hosp, Dept Hematol, Stockholm, Sweden.;Karolinska Inst, Ctr Hematol & Regenerat Med HERM, Dept Med Huddinge, Stockholm, Sweden
Pandzic, Tatjana (author)
Uppsala universitet,Science for Life Laboratory, SciLifeLab,Institutionen för immunologi, genetik och patologi
Illman, Johanna (author)
Division of Hematology, Helsinki University Hospital, Comprehensive Cancer Center, Helsinki, Finland,Helsinki Univ Hosp, Comprehens Canc Ctr, Div Hematol, Helsinki, Finland
show more...
Nilsson, Lars (author)
Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Lund, Sweden,Skane Univ Hosp, Dept Hematol Oncol & Radiat Phys, Lund, Sweden
Weström, Simone (author)
Uppsala universitet,Karolinska Institutet,Science for Life Laboratory, SciLifeLab,Institutionen för immunologi, genetik och patologi
Ejerblad, Elisabeth (author)
Uppsala universitet,Karolinska Institutet,Hematologi
Olesen, Gitte (author)
Department of Hematology, Aarhus University Hospital, Aarhus, Denmark,Aarhus Univ Hosp, Dept Hematol, Aarhus, Denmark
Björklund, Andreas (author)
Karolinska Institutet,Karolinska Univ Hosp Huddinge, Karolinska Comprehens Canc Ctr, Dept Cellular Therapy & Allogene Stem Cell Transp, Stockholm, Sweden
Olsnes Kittang, Astrid (author)
Department of Medicine, Haukeland University Hospital, Bergen, Norway; Department of Clinical Science, University of Bergen, Bergen, Norway,Haukeland Hosp, Dept Med, Bergen, Norway.;Univ Bergen, Dept Clin Sci, Bergen, Norway
Werlenius, Olle (author)
Section of Hematology and Coagulation, Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden,Sahlgrens Univ Hosp, Dept Med, Sect Hematol & Coagulat, Gothenburg, Sweden
Lorentz, Fryderyk (author)
Department of Hematology, Norrlands University Hospital, Umeå, Sweden,Norrlands Univ Hosp, Dept Hematol, Umeå, Sweden
Rasmussen, Bengt, 1970- (author)
Örebro universitet,Institutionen för medicinska vetenskaper,Department of Medicine, Faculty of Medicine and Health, Örebro University, Örebro, Sweden,Örebro Univ, Fac Med & Hlth, Dept Med, Örebro, Sweden
Cammenga, Jörg (author)
Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Lund, Sweden; Division of Molecular Medicine and Gene Therapy, Lund University, Lund, Sweden,Skane Univ Hosp, Dept Hematol Oncol & Radiat Phys, Lund, Sweden.;Lund Univ, Div Mol Med & Gene Therapy, Lund, Sweden
Weber, Duruta (author)
Department of Hematology, Odense University Hospital, Odense, Denmark,Odense Univ Hosp, Dept Hematol, Odense, Denmark
Lindholm, Carolin (author)
Department of Hematology, Karolinska University Hospital, Stockholm, Sweden; Department of Medicine, Huddinge, Centre for Hematology and Regenerative Medicine (HERM), Karolinska Institute, Stockholm, Sweden,Karolinska Univ Hosp, Dept Hematol, Stockholm, Sweden.;Karolinska Inst, Ctr Hematol & Regenerat Med HERM, Dept Med Huddinge, Stockholm, Sweden
Wiggh, Joel (author)
Department of Hematology, Karolinska University Hospital, Stockholm, Sweden; Department of Medicine, Huddinge, Centre for Hematology and Regenerative Medicine (HERM), Karolinska Institute, Stockholm, Sweden,Karolinska Univ Hosp, Dept Hematol, Stockholm, Sweden.;Karolinska Inst, Ctr Hematol & Regenerat Med HERM, Dept Med Huddinge, Stockholm, Sweden
Dimitriou, Marios (author)
Karolinska Institutet,Karolinska Inst, Ctr Hematol & Regenerat Med HERM, Dept Med Huddinge, Stockholm, Sweden
Moen, Ann Elin (author)
Department of Hematology, Oslo University Hospital, Rikshospitalet, Oslo, Norway,Oslo Univ Hosp, Dept Hematol, Rikshosp, Oslo, Norway
Yip Lundström, Laimei (author)
Division of Biostatistics, Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden,Karolinska Inst, Inst Environm Med, Div Biostat, Stockholm, Sweden
von Bahr, Lena (author)
Section of Hematology and Coagulation, Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden,Sahlgrens Univ Hosp, Dept Med, Sect Hematol & Coagulat, Gothenburg, Sweden
Baltzer-Sollander, Karin (author)
Department of Genetics, HUS Diagnostic Centre, Helsinki University Hospital and University of Helsinki, Helsinki, Finland,Helsinki Univ Hosp, HUS Diagnost Ctr, Dept Genet, Helsinki, Finland.;Univ Helsinki, Helsinki, Finland
Jädersten, Martin (author)
Karolinska Institutet,Karolinska Univ Hosp, Dept Hematol, Stockholm, Sweden.;Karolinska Inst, Ctr Hematol & Regenerat Med HERM, Dept Med Huddinge, Stockholm, Sweden
Kytölä, Soili (author)
Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden,Karolinska Univ Hosp, Dept Clin Genet, Stockholm, Sweden
Walldin, Gunilla (author)
Department of Medicine, Huddinge, Centre for Hematology and Regenerative Medicine (HERM), Karolinska Institute, Stockholm, Sweden,Karolinska Inst, Ctr Hematol & Regenerat Med HERM, Dept Med Huddinge, Stockholm, Sweden
Ljungman, Per (author)
Karolinska Institutet,Karolinska Univ Hosp Huddinge, Karolinska Comprehens Canc Ctr, Dept Cellular Therapy & Allogene Stem Cell Transp, Stockholm, Sweden
Groenbaek, Kirsten (author)
Department of Hematology, Rigshospitalet, Copenhagen, Copenhagen, Denmark,Rigshospitalet, Dept Hematol, Copenhagen, Denmark
Mielke, Stephan (author)
Karolinska Institutet,Karolinska Univ Hosp Huddinge, Karolinska Comprehens Canc Ctr, Dept Cellular Therapy & Allogene Stem Cell Transp, Stockholm, Sweden.;Karolinska Inst, Dept Lab Med, Stockholm, Sweden
Jacobsen, Sten Eirik W. (author)
Department of Medicine, Huddinge, Centre for Hematology and Regenerative Medicine (HERM), Karolinska Institute, Stockholm, Sweden,Karolinska Inst, Ctr Hematol & Regenerat Med HERM, Dept Med Huddinge, Stockholm, Sweden
Ebeling, Freja (author)
Division of Hematology, Helsinki University Hospital, Comprehensive Cancer Center, Helsinki, Finland,Helsinki Univ Hosp, Comprehens Canc Ctr, Div Hematol, Helsinki, Finland
Cavelier, Lucia (author)
Department of Genetics, HUS Diagnostic Centre, Helsinki University Hospital and University of Helsinki, Helsinki, Finland,Helsinki Univ Hosp, HUS Diagnost Ctr, Dept Genet, Helsinki, Finland.;Univ Helsinki, Helsinki, Finland
Smidstrup Friis, Lone (author)
Department of Hematology, Rigshospitalet, Copenhagen, Copenhagen, Denmark,Rigshospitalet, Dept Hematol, Copenhagen, Denmark
Dybedal, Ingunn (author)
Department of Hematology, Oslo University Hospital, Rikshospitalet, Oslo, Norway,Oslo Univ Hosp, Dept Hematol, Rikshosp, Oslo, Norway
Hellström-Lindberg, Eva (author)
Department of Hematology, Karolinska University Hospital, Stockholm, Sweden; Department of Medicine, Huddinge, Centre for Hematology and Regenerative Medicine (HERM), Karolinska Institute, Stockholm, Sweden,Karolinska Univ Hosp, Dept Hematol, Stockholm, Sweden.;Karolinska Inst, Ctr Hematol & Regenerat Med HERM, Dept Med Huddinge, Stockholm, Sweden
show less...
Karolinska Institutet Karolinska Univ Hosp, Dept Hematol, Stockholm, Sweden;Karolinska Inst, Ctr Hematol & Regenerat Med HERM, Dept Med Huddinge, Stockholm, Sweden (creator_code:org_t)
American Society of Clinical Oncology, 2024
2024
English.
In: Journal of Clinical Oncology. - : American Society of Clinical Oncology. - 0732-183X .- 1527-7755. ; 42:12, s. 1378-1390
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • PURPOSE: Clinical relapse is the major threat for patients with myelodysplastic syndrome (MDS) undergoing hematopoietic stem-cell transplantation (HSCT). Early detection of measurable residual disease (MRD) would enable preemptive treatment and potentially reduced relapse risk.METHODS: Patients with MDS planned for HSCT were enrolled in a prospective, observational study evaluating the association between MRD and clinical outcome. We collected bone marrow (BM) and peripheral blood samples until relapse, death, or end of study 24 months after HSCT. Patient-specific mutations were identified with targeted next-generation sequencing (NGS) panel and traced using droplet digital polymerase chain reaction (ddPCR).RESULTS: Of 266 included patients, estimated relapse-free survival (RFS) and overall survival (OS) rates 3 years after HSCT were 59% and 64%, respectively. MRD results were available for 221 patients. Relapse was preceded by positive BM MRD in 42/44 relapses with complete MRD data, by a median of 71 (23-283) days. Of 137 patients in continuous complete remission, 93 were consistently MRD-negative, 39 reverted from MRD+ to MRD-, and five were MRD+ at last sampling. Estimated 1 year-RFS after first positive MRD was 49%, 39%, and 30%, using cutoff levels of 0.1%, 0.3%, and 0.5%, respectively. In a multivariate Cox model, MRD (hazard ratio [HR], 7.99), WHO subgroup AML (HR, 4.87), TP53 multi-hit (HR, 2.38), NRAS (HR, 3.55), and acute GVHD grade III-IV (HR, 4.13) were associated with shorter RFS. MRD+ was also independently associated with shorter OS (HR, 2.65). In a subgroup analysis of 100 MRD+ patients, presence of chronic GVHD was associated with longer RFS (HR, 0.32).CONCLUSION: Assessment of individualized MRD using NGS + ddPCR is feasible and can be used for early detection of relapse. Positive MRD is associated with shorter RFS and OS (ClinicalTrials.gov identifier: NCT02872662).

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Hematologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Hematology (hsv//eng)

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view